Gary Wood

As Chief Scientific Officer, Dr. Wood brings an extensive background in immunology and the company’s cancer immunotherapy technology. Dr. Wood is the inventor and principal developer of the company’s T cell-based immunotherapy that is being advanced for humans by TVAX Biomedical and for veterinary patients by ELIAS. He is the Founder and Board Chair of TVAX Biomedical. Dr. Wood guided the development of TVAX Immunotherapy from concept through its most recent human clinical trials. Dr. Wood organized and coordinated the Phase 1/2 clinical trials performed at the University of Kansas Medical Center and at Wayne State University and managed the scientific/clinical teams that performed the trials. Dr. Wood was Professor of Pathology, Director of the Diagnostic Immunology Laboratory, and Director of the Cancer Immunotherapy Laboratory at KU Medical Center. Dr. Wood also was a Professor of Medicine and Director of the Cancer Immunotherapy Laboratory at Wayne State University. Dr. Wood has a BA from Kalamazoo College and a Ph.D. from the State University of New York at Buffalo.